Kingsford Pharmaceuticals

2600 Eastern Beltway

Dallas, Texas 75225
(214) 668-9234
(214) 668-2349 FAX

For Release: September 28, 2016

Brandon Yost
Public Relations Director
(714)-600-9946
brandonyost@csu.fullerton.edu

Possible Cure for West Nile Virus

DALLAS September 28, 2016 Kingsford Pharmaceuticals is thrilled to
announce its new breakthrough medication, X23, today. This new
medication is in the form of a pill and can effectively treat the West Nile
Virus. The patient takes X23 within 2 weeks of infection and it completely
eliminates all traces of the virus from the human body.
The pill still needs to be tested and approved by the Food & Drug
Administration (FDA) before X23 can be offered for sale to the public.
This medication is a medical breakthrough that will have profound
implications on human health. X23 has the potential to save thousands of
lives. We are confident of securing FDA approval quickly so that we can get
X23 into the hands of doctors and nurses all over the world, said CEO
Roberta Cruz-Suarez.
FDA testing of X23 is set to begin in two weeks.
Founded in 1945, Kingsford Pharmaceuticals is constantly innovating to fight disease
and save lives by delivering quality medical products for over 70 years.